Complementary effects of HDAC inhibitor 4-PB on gap junction communication and cellular export mechanisms support restoration of chemosensitivity of PDAC cells

Pancreatic ductal adenocarcinoma (PDAC) is a fatal disease and one of the cancer entities with the lowest life expectancy. Beside surgical therapy, no effective therapeutic options are available yet. Here, we show that 4-phenylbutyrate (4-PB), a known and well-tolerable inhibitor of histone deacetyl...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Ammerpohl, O, Trauzold, A, Schniewind, B, Griep, U, Pilarsky, C, Grutzmann, R, Saeger, H-D, Janssen, O, Sipos, B, Kloppel, G, Kalthoff, H
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2007
Assuntos:
Translational Therapeutics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2360208/
https://ncbi.nlm.nih.gov/pubmed/17164759
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6603511
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados